COSCIENS Biopharma Inc. (CSCI)
NASDAQ: CSCI · Real-Time Price · USD
2.500
-0.200 (-7.41%)
At close: Dec 20, 2024, 4:00 PM
2.600
+0.100 (4.00%)
After-hours: Dec 20, 2024, 4:00 PM EST
COSCIENS Biopharma Employees
COSCIENS Biopharma had 12 employees as of December 31, 2020. The number of employees decreased by 44 or -78.57% compared to the previous year.
Employees
12
Change
-44
Growth
-78.57%
Revenue / Employee
$402,833
Profits / Employee
-$1,934,083
Market Cap
8.52M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2020 | 12 | -44 | -78.57% |
| Dec 31, 2014 | 56 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Evogene | 142 |
| Applied DNA Sciences | 55 |
| RedHill Biopharma | 53 |
| Viracta Therapeutics | 40 |
| Purple Biotech | 20 |
| BioCardia | 20 |
| QT Imaging Holdings | 14 |
| SeaStar Medical Holding | 12 |
CSCI News
- 5 weeks ago - COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs - GlobeNewsWire
- 2 months ago - COSCIENS Biopharma Announces Change to Board of Directors - GlobeNewsWire
- 2 months ago - COSCIENS Biopharma Announces Appointment of Pierre Labbé as Director - GlobeNewsWire
- 3 months ago - COSCIENS Biopharma Inc. Provides Updates on Merger Integration, Management Succession Plans and Ongoing Development Programs - GlobeNewsWire
- 4 months ago - COSCIENS Biopharma Inc. Announces Top-Line Results of Phase 3 DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency - GlobeNewsWire
- 4 months ago - COSCIENS Biopharma Inc. Reports Second Quarter 2024 Financial Results - GlobeNewsWire